Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content

Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

(2011) M. van Hoek et al.   DIABETOLOGIA

Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation

(2010) Herbert Tilg et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

The impact of liver fat vs visceral fat in determining categories of prediabetes

(2010) K. Kantartzis et al.   DIABETOLOGIA

Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial Hypobetalipoproteinemia

(2010) Anastassia Amaro et al.   GASTROENTEROLOGY

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease

(2010) P. Dongiovanni et al.   GUT

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

(2010) M. Stepanova et al.   GUT

Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance

(2010) Julia Kozlitina et al.   HEPATOLOGY

Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease

(2010) Kitt Falk Petersen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic Susceptibility to Hepatic Steatosis

(2010) Anna Mae Diehl   NEW ENGLAND JOURNAL OF MEDICINE

Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene

(2009) K. Kantartzis et al.   DIABETES

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

(2009) A. Kotronen et al.   DIABETOLOGIA

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

(2009) Nina F. Schwenzer et al.   JOURNAL OF HEPATOLOGY

Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

(2009) E. Fabbrini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification and Characterization of Metabolically Benign Obesity in Humans

(2008) Norbert Stefan   ARCHIVES OF INTERNAL MEDICINE

Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke

(2008) Cornelia Weikert et al.   CIRCULATION

TheDGAT2gene is a candidate for the dissociation between fatty liver and insulin resistance in humans

(2008) Konstantinos Kantartzis et al.   CLINICAL SCIENCE

Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes

(2008) N. Stefan et al.   DIABETES

Causes and Metabolic Consequences of Fatty Liver

(2008) Norbert Stefan et al.   ENDOCRINE REVIEWS

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

(2008) K Kantartzis et al.   GUT

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

(2008) Stefano Romeo et al.   NATURE GENETICS

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

(2008) T. I. Pollin et al.   SCIENCE

Fatty Liver

(2007) Anna Kotronen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY